*ST长药、海南华铁收到行政处罚事先告知书 投资者可索赔

Core Viewpoint - Both *ST Changyao and Hainan Huatie have received administrative penalty notices from the China Securities Regulatory Commission (CSRC) for various violations, leading to potential claims from investors [2][4]. Group 1: *ST Changyao Violations - From 2021 to 2023, *ST Changyao's subsidiaries fabricated false inventory and sales documents, resulting in inflated revenues of 215.32 million yuan, 283.74 million yuan, and 233.63 million yuan for the respective years, which accounted for 9.12%, 17.57%, and 19.51% of the reported revenues [2][5]. - The company also inflated total profits by 56.40 million yuan, 63.38 million yuan, and 43.71 million yuan during the same period, representing 35.62%, 88.23%, and 6.42% of the reported total profits [2][5]. - In 2022, due to improper loss recognition related to a project, *ST Changyao's profit was inflated by 4.55 million yuan, which was 6.34% of the reported total profits for that year [2][5]. Group 2: Hainan Huatie Violations - Hainan Huatie's violations are linked to a significant contract known as the "computing power service agreement," with a total expected contract value of 3.69 billion yuan [2][5]. - The company failed to disclose critical terms of the contract that could impact its execution, leading to incomplete announcements regarding the contract [2][5]. - Additionally, Hainan Huatie did not timely disclose significant developments or changes related to the contract, including delays in delivery and subsequent amendments to the delivery schedule [2][5]. Group 3: Investor Claims - Investors who purchased *ST Changyao shares between April 28, 2022, and November 7, 2025, and sold or held them after November 8, 2025, may be eligible for compensation [2][5]. - Similarly, investors who bought Hainan Huatie shares between March 5, 2025, and September 30, 2025, and sold or held them after October 1, 2025, may also qualify for claims [2][5].